TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3113295

Group type: EXPERIMENTAL
Intervention: Inhaled albuterol (180 microgram) administered 15 minutes prior to exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cromolyn (20 mg) administered 15 minutes prior to exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cromolyn (20 mg) administered 4 times/day for 2 or 4 weeks
Number of subjects: 80
Study: 29472143

Group type: EXPERIMENTAL
Intervention: Laparoscopic mesh sacropexy (LS)
Number of subjects: 257
Study: 24164537

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine and L-asparaginase (experimental arm)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Standard-dose cytarabine, oral 6-mercaptopurine, and cyclophosphamide (standard arm)
Number of subjects: 310
Study: 23291141

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m² plus cisplatin 25 mg/m² d1‐3 and 40 Gy of radiation therapy (Arm A)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Cisplatin 25 mg/m² d1‐3 plus fluorouracil 600 mg/m² d1 ∼ 5 and 40 Gy of radiation therapy (Arm B)
Number of subjects: 154
Study: 20096753

Group type: EXPERIMENTAL
Intervention: gentle Continuous Punishment (gentle COP) policies
Number of subjects: 0
Study: 18339420

Group type: EXPERIMENTAL
Intervention: Extended release oxybutynin 10 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phenazopyridine 200 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 15634033

Group type: EXPERIMENTAL
Intervention: Delavirdine 400mg three times daily
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: N-delavirdine
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Delavirdine
Number of subjects: 234
Study: 12711838

Group type: EXPERIMENTAL
Intervention: NAC 600 mg/day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NAC 1,800 mg/day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NAC 1,800 mg/day (after washout period)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NAC (both dosages)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No therapy (control group A)
Number of subjects: 40
Study: 10234397

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.4 mg/kg
Number of subjects: 90
Study: 8527619

Group type: EXPERIMENTAL
Intervention: roxatidine 150 mg in the early evening
Number of subjects: 276

Group type: COMPARATOR
Intervention: roxatidine 150 mg at bedtime
Number of subjects: 276
Study: 2312038

Group type: EXPERIMENTAL
Intervention: Ranitidine maintenance therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ranitidine treatment in patients with severe non-stenosing bulb deformity
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment in patients with severe non-stenosing bulb deformity
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment in patients with normal or mildly deformed bulb
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ranitidine treatment in patients with normal duodenal bulb morphology
Number of subjects: 60
Study: 384941

Group type: EXPERIMENTAL
Intervention: Primary closure (67 patients)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Colostomy (72 patients)
Number of subjects: 268
Study: 29935999

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRE)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Prolonged Exposure (PE)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both VRE and PE
Number of subjects: 108
Study: 26370109

Group type: EXPERIMENTAL
Intervention: 1-sample FIT
Number of subjects: 8197

Group type: EXPERIMENTAL
Intervention: 2-sample FIT
Number of subjects: 8197
Study: 25485802

Group type: EXPERIMENTAL
Intervention: Bolus technique on the right side
Number of subjects: 32

Group type: COMPARATOR
Intervention: Serial puncture technique on the left side
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Serial puncture technique
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Bolus technique
Number of subjects: 32
Study: 23680985

Group type: EXPERIMENTAL
Intervention: Self-management lifestyle physical activity intervention delivered by a health coach using a workbook and alternating one-on-one telephone counseling and computer-assisted telephone calls for 20 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-management lifestyle physical activity intervention
Number of subjects: 0
Study: 21118954

Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy (RCT)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Failure of RCT-induced downregulation of survivin
Number of subjects: 116
Study: 19263066

Group type: EXPERIMENTAL
Intervention: Pre-operative intravenous dexamethasone (0.5 mg/kg) combined with glossopharyngeal nerve block (3 ml of 0.5% bupivacaine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-operative intravenous dexamethasone (0.5 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glossopharyngeal nerve block (3 ml of 0.5% bupivacaine)
Number of subjects: 0
Study: 16881949

Group type: EXPERIMENTAL
Intervention: Modified consent process (consent form written at a sixth-grade level, read to participants, combined with 7 comprehension questions and targeted education, repeated until comprehension achieved)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Lower literacy (s-TOHFLA<23)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Being black
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Not speaking English as a primary language
Number of subjects: 204
Study: 14764931

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 20942

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20942
Study: 11772265

Group type: EXPERIMENTAL
Intervention: New antifungal agents (terbinafine, itraconazole, fluconazole)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ketoconazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Griseofulvin
Number of subjects: 0
Study: 9238872

Group type: EXPERIMENTAL
Intervention: Stabilized stannous fluoride dentifrice (Crest Plus Gum Care, 0.454% SnF2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triclosan/copolymer dentifrice (Colgate Total, 0.30% triclosan, 2.0% Gantrez co‐polymer)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional fluoride dentifrice (0.243% NaF)
Number of subjects: 0
Study: 7944842

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (first or second intramuscular dose)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (revaccination)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Primary vaccination
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Revaccination
Number of subjects: 52
Study: 3130253

Group type: EXPERIMENTAL
Intervention: Vigabatrin (1-3 g/day, stratified according to body weight)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 29857756

Group type: EXPERIMENTAL
Intervention: Acoustic-only stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electric-only stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28787505

Group type: EXPERIMENTAL
Intervention: Suction-based extraction device
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Intra-aortic filtration device
Number of subjects: 383

Group type: COMPARATOR
Intervention: Control (standard aortic cannula)
Number of subjects: 383
Study: 26426148

Group type: EXPERIMENTAL
Intervention: Breath‐Body‐Mind Workshop (BBMW)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Educational seminar
Number of subjects: 29
Study: 23735514

Group type: EXPERIMENTAL
Intervention: Selumetinib plus dacarbazine
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo plus dacarbazine
Number of subjects: 91
Study: 20684895

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 20
Study: 18211616

Group type: EXPERIMENTAL
Intervention: Apricitabine with trimethoprim-sulphamethoxazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Apricitabine alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trimethoprim-sulphamethoxazole
Number of subjects: 0
Study: 17010732

Group type: EXPERIMENTAL
Intervention: Screening arm (prostate-specific antigen testing, digital rectal examination, transrectal ultrasonography, sextant biopsies)
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Second screening round
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: First screening round
Number of subjects: 42376
Study: 12728489

Group type: EXPERIMENTAL
Intervention: Premedicated with oral midazolam 0.5 mg.kg‐1 (group A (+); n = 19)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Without premedication (group A (‐); n = 12)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Group B (7-12 months; n = 12)
Number of subjects: 43
Study: 11122102

Group type: EXPERIMENTAL
Intervention: Guthrie card samples
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blood donors
Number of subjects: 0
Study: 9115563

Group type: EXPERIMENTAL
Intervention: Trephination plus suturing (group TS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Suturing alone (group S)
Number of subjects: 64
Study: 1454316

Group type: EXPERIMENTAL
Intervention: Single-plate Molteno implantation
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Double-plate Molteno implantation
Number of subjects: 132
Study: 6095706

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0
Study: 31372099

Group type: EXPERIMENTAL
Intervention: Conventional physical therapy and visceral manipulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional physical therapy and placebo visceral manipulation
Number of subjects: 20
Study: 29967197

Group type: EXPERIMENTAL
Intervention: Higher dose edoxaban regimen (60 mg QD)
Number of subjects: 3029

Group type: EXPERIMENTAL
Intervention: Dose-reduced higher dose edoxaban regimen (30 mg QD)
Number of subjects: 3029

Group type: EXPERIMENTAL
Intervention: Lower dose edoxaban regimen (30 mg QD)
Number of subjects: 3029

Group type: EXPERIMENTAL
Intervention: Dose-reduced lower dose edoxaban regimen (15 mg QD)
Number of subjects: 3029

Group type: EXPERIMENTAL
Intervention: Inhibition of endogenous FXa activity
Number of subjects: 3029
Study: 26675776

Group type: EXPERIMENTAL
Intervention: Dairy meal (skim milk, low-fat yogurt, cheese, and bread)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Red meat meal (lean red meat, bread, and orange juice)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Red meat meal
Number of subjects: 43

Group type: COMPARATOR
Intervention: Dairy meal
Number of subjects: 43
Study: 24831970

Group type: EXPERIMENTAL
Intervention: Light/Dark (LD) environment
Number of subjects: 38

Group type: COMPARATOR
Intervention: Continuous Light (LL) environment
Number of subjects: 38
Study: 22219221

Group type: EXPERIMENTAL
Intervention: GSK598809 (175 mg single oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK598809 (175 mg single oral dose) + Alcohol infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20055569

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program
Number of subjects: 158

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 158
Study: 18209689

Group type: EXPERIMENTAL
Intervention: Rotational Angiography (RA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard Angiography (SA)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Comparison of severity of stenoses
Number of subjects: 78
Study: 15185803

Group type: EXPERIMENTAL
Intervention: Oralgiene 60 Second Time Machine powered toothbrush
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Mickey Mouse powered toothbrush
Number of subjects: 58

Group type: COMPARATOR
Intervention: Manual toothbrush (Oral‐B Rugrats 20)
Number of subjects: 58
Study: 12474069

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (500 mg Ca(2+))
Number of subjects: 31

Group type: COMPARATOR
Intervention: No calcium supplementation (control group)
Number of subjects: 31
Study: 10036599

Group type: EXPERIMENTAL
Intervention: Desogestrel 75 micrograms/day
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Levonorgestrel 30 micrograms/day
Number of subjects: 1320
Study: 7584298

Group type: EXPERIMENTAL
Intervention: Three study-recall trials on Swahili-English translation equivalents
Number of subjects: 200
Study: 2674028

Group type: EXPERIMENTAL
Intervention: 10 mg xipamide + 30 mg triamterene (A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 25 mg hydrochlorothiazide + 50 mg triamterene (B)
Number of subjects: 30
Study: 29925915

Group type: EXPERIMENTAL
Intervention: Opt-out intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Opt-in intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subgroup analysis (EHR portal messaging)
Number of subjects: 0
Study: 28624715

Group type: EXPERIMENTAL
Intervention: Group physical activity program (12 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Individual physical activity program (12 weeks)
Number of subjects: 26
Study: 26308937

Group type: EXPERIMENTAL
Intervention: Individual physical therapy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Group class intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 58
Study: 23584279

Group type: EXPERIMENTAL
Intervention: Low-drop/low-heel height shoes (SHOES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Foot strike retraining (TRAIN)
Number of subjects: 30
Study: 20473910

Group type: EXPERIMENTAL
Intervention: TT genotype
Number of subjects: 2617
Study: 19926547

Group type: EXPERIMENTAL
Intervention: Job strain
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: High control
Number of subjects: 1236
Study: 17066964

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waiting-list control (WLC)
Number of subjects: 45
Study: 14530147

Group type: EXPERIMENTAL
Intervention: Statistical message
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Narrative message
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Self-assessment manipulation
Number of subjects: 141
Study: 11097613

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (50 mg/ml for 5 minutes)
Number of subjects: 113

Group type: COMPARATOR
Intervention: mitomycin C (0.4 mg/ml for 2 minutes)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil
Number of subjects: 113

Group type: COMPARATOR
Intervention: mitomycin C
Number of subjects: 113
Study: 9387586

Group type: EXPERIMENTAL
Intervention: Pre-education group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-education group
Number of subjects: 0
Study: 1561975

Group type: EXPERIMENTAL
Intervention: Pacing group (VVI or DDD pacemaker implant)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonpacing group (no therapy)
Number of subjects: 60
Study: 3929304

Group type: EXPERIMENTAL
Intervention: 12 mg metergoline (MET)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 10 mg diazepam (DZ)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PB)
Number of subjects: 12
Study: 29684147

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Longer infusions of Meropenem
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Meropenem for culture-proven Gram-negative LOS
Number of subjects: 167
Study: 26041481

Group type: EXPERIMENTAL
Intervention: Epidermal growth factor (EGF) ointment
Number of subjects: 52
Study: 25111880

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 14224

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 14224

Group type: COMPARATOR
Intervention: Placebo (FIT)
Number of subjects: 14224

Group type: COMPARATOR
Intervention: Placebo (HORIZON-PFT)
Number of subjects: 14224

Group type: EXPERIMENTAL
Intervention: Pooled data from FIT and HORIZON-PFT
Number of subjects: 14224
Study: 23146365

Group type: EXPERIMENTAL
Intervention: Participants aged 65 to 75 years
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Participants with waist circumference ≥90 cm
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Participants with grade 2 hypertension
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Participants with grade 3 hypertension
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Participants with heart rate at rest 70 to 80 beats/min
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Participants with heart rate at rest ≥80 beats/min
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Participants with poor sleeping quality
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Men inland versus coastal residents
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Women inland versus coastal residents
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Men with BMI ≥25 kg/m²
Number of subjects: 3128

Group type: EXPERIMENTAL
Intervention: Women with BMI ≥25 kg/m²
Number of subjects: 3128
Study: 21516742

Group type: EXPERIMENTAL
Intervention: Intravenous alpha-lipoic acid (600 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 18059990

Group type: EXPERIMENTAL
Intervention: Quadriceps CAR in CAI group (involved limb)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Quadriceps CAR in CAI group (uninvolved limb)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Quadriceps CAR in control group (sham involved)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Quadriceps CAR in control group (sham uninvolved)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Hamstrings CAR in CAI group (averaged)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Hamstrings CAR in control group (averaged)
Number of subjects: 41
Study: 15630501

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) therapy during the first weeks of life
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no Epo therapy)
Number of subjects: 0
Study: 12710842

Group type: EXPERIMENTAL
Intervention: Dalteparin (5,000 IU per day for 14 days)
Number of subjects: 3300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3300
Study: 10188602

Group type: EXPERIMENTAL
Intervention: Assisted rehabilitation and measurement (ARM) Guide during guided movement
Number of subjects: 8

Group type: COMPARATOR
Intervention: Assisted rehabilitation and measurement (ARM) Guide
Number of subjects: 8
Study: 7586935

Group type: EXPERIMENTAL
Intervention: Low-sodium diet (10 mmol sodium/24 hours)
Number of subjects: 7

Group type: COMPARATOR
Intervention: High-sodium diet (250 mmol sodium/24 hours)
Number of subjects: 7
Study: 2138172

Group type: EXPERIMENTAL
Intervention: 12% ammonium lactate lotion (Lac‐Hydrin) applied twice daily for 16 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 58
Study: 7222872

Group type: EXPERIMENTAL
Intervention: Metronidazole prophylaxis
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 103
Study: 30744172

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise under normoxia (FIO₂: 0.209)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise under hypoxia (FIO₂: 0.154)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate hypoxia (FIO₂: 0.154)
Number of subjects: 20
Study: 28642340

Group type: EXPERIMENTAL
Intervention: Low-fit obese (LF-OB, n=27)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High-fit obese (HF-OB, n=27)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Obese individuals (OB, LF-OB, HF-OB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Age-matched healthy controls (AMHC, n=16)
Number of subjects: 70
Study: 26445486

Group type: EXPERIMENTAL
Intervention: Tailored Written + Tailored Video (TW + TV)
Number of subjects: 2525

Group type: EXPERIMENTAL
Intervention: Tailored Written (TW)
Number of subjects: 2525
Study: 23551983

Group type: EXPERIMENTAL
Intervention: Intravenous propofol/midazolam
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Enteral melatonin/hydroxyzine/lorazepam
Number of subjects: 348
Study: 21659891

Group type: EXPERIMENTAL
Intervention: HiMF training (HiMFT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: LoMF training (LoMFT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: HiMF control (HiMFC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: LoMF control (LoMFC)
Number of subjects: 55
Study: 17933414

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100mg
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 17073156

Group type: EXPERIMENTAL
Intervention: Aralox phytopreparation containing Aralia mandshurica and Engelhardtia chrysolepis extracts
Number of subjects: 32
Study: 12774016

Group type: EXPERIMENTAL
Intervention: 500 ng/kg IL-12 subcutaneously twice weekly for 12 weeks
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: IL-12 therapy
Number of subjects: 225
Study: 11200372

Group type: EXPERIMENTAL
Intervention: Enterococcus faecium probiotic (150 ml daily, 4.5 x 10^9 to 7.5 x 10^9 CFU E. faecium for 10 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vancomycin (125 mg orally q.i.d. for 10 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: VRE detection in volunteers
Number of subjects: 40
Study: 9357377

Group type: EXPERIMENTAL
Intervention: Albuterol by Ventolin metered-dose inhaler (2 puffs, 90 micrograms/puff)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Albuterol sulfate powder (Rotacaps) by dry powder inhaler (2 inhalations, 100 micrograms/puff)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lactose powder by dry powder inhaler (2 inhalations, 12.5 mg/inhalation)
Number of subjects: 12
Study: 1588824

Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2862995

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with low‐dose continuous prednisone (7.5 mg daily)
Number of subjects: 505

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy without prednisone
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Induced amenorrhea
Number of subjects: 505